The mutations that drive cancer. Paul Edwards. Department of Pathology and Cancer Research UK Cambridge Institute, University of Cambridge
|
|
- James Job Morgan
- 6 years ago
- Views:
Transcription
1 The mutations that drive cancer Paul Edwards Department of Pathology and Cancer Research UK Cambridge Institute, University of Cambridge
2 Previously on Cancer... hereditary predisposition Normal Cell Slightly Abnormal More Abnormal Malignant? Gene changes mutations + epigenetic change + viruses + mobile elements accelerated by Genetic Instability
3 Which genes are altered in cancer? - all sorts of different pathways and systems - Mitogenic signalling pathways e.g. Wnt signalling pathway*, Receptor tyrosine kinase pathways* Rb control of cell cycle Hedgehog pathway, Notch pathway, Hippo pathway... - Inhibitory signalling, e.g. TGF-β pathway* - Transcription control systems - transcription factors - p53 - beta-catenin, MYC and ETS families - hormone receptors ER - chromatin / histone modifiers - Cell adhesion, e.g. cadherin E in breast - telomerase - DNA repair and mitotic processes - Carbohydrate metabolism (IDH1 in gliomas and AML) - etc., etc.!
4 A weird example
5 citric acid cycle citrate A weird example isocitrate isocitrate dehydrogenases hydroxyglutarate alphaketoglutarate DNA hypermethylation? = epigenetic instability? isocitrate dehydrogenase IDH1 mutated in majority glioblastomas, occasional leukaemias,
6 What sorts of mutations alter the genes? All sorts of mutation
7 What sorts of mutations alter the genes? Sequence changes, e.g. TCGAGCTATGTGTCTCTAGGTCGGT TCGAGCTATGAGTCTCTAGGTCGGT Small-scale changes STRUCTURAL changes, e.g. Large-scale changes
8 What sorts of mutations alter the genes? - single base pair change, e.g. RAS, p53... Small-scale changes - chromosome translocation - Amplification (lot of copies of gene) - Duplication - Deletion Large-scale changes
9 What sorts of mutations alter the genes? - single base pair change - Indel = Small insert or deletion ->frameshift Small-scale changes - chromosome translocation APC classic example, truncated in colon - Amplification (lot of copies of gene) - Duplication - Deletion Large-scale changes
10 What sorts of mutations alter the genes? - single base pair change - Indel = Small insert or deletion ->frameshift Small-scale changes - chromosome translocation APC classic example, truncated in colon - Amplification (lot of copies of gene) - Duplication - Deletion Large-scale changes
11 What sorts of mutations alter the genes? - single base pair change - Indel = Small insert or deletion ->frameshift Small-scale changes - chromosome translocation APC classic example, truncated in colon, first mutation in Vogelstein s model of colon cancer, - Amplification (lot of copies of gene) - Duplication - Deletion Large-scale changes
12 Deleting the APC gene in colon Wild-type APC deleted Crypt region Sansom, O.J. et al., Genes & development Crypt region has expanded
13 What sorts of mutations alter the genes? - single base pair change - Indel = Small insert or deletion ->frameshift Small-scale changes - chromosome translocation...cca ATA AAT TAT AGT P I N Y S... - Amplification (lot of copies of gene) - Duplication...CCA ATA AAT TTA TAG P I N L *STOP - Deletion APC classic example, truncated in colon T truncated APC protein Large-scale changes
14 What sorts of mutations alter the genes? - single base pair change - Indel = Small insert or deletion ->frameshift - (e.g. APC in practical) Small-scale changes - Deletion - Inversion - Duplication - Amplification - Chromosome translocation Large-scale changes
15 Duplication and amplification Gene e.g. EGFR Duplication tandem OR inverted Amplification Amplified gene
16 Chromosome translocation reciprocal translocation OR unbalanced translocation
17 Chromosome translocation translocation beginning of gene A end of gene B
18 What sorts of mutations alter the genes? How do we study these mutations?
19 How did we discover cancer genes historically before large scale sequencing Viruses: retrovirus oncogenes e.g. RAS, MYC (RAt Sarcoma, MYeloblastosis C) DNA tumour viruses p53 - Deletion Hereditary predisposition to cancer - Duplication e.g. breast cancer prediposition BRCA1, BRCA2 polyposis coli APC - Amplification (lot of copies of gene) Large-scale changes - Chromosome translocation
20 p53 is a hub for stress signalling DNA damage telomeres short aberrant growth signals ATM, ATR kinases (inhibits CDK/cyclin complexes) p21 p53 p53 p53 p53 p14 ARF DNA Viruses: e.g. HPV AdenoV RB pathway cycle arrest apoptosis
21 How do we study the alterations/mutations? sequencing Small-scale changes - Deletion - Duplication - Amplification (lot of copies of gene) Large-scale changes - Chromosome translocation
22 Passengers versus Drivers Normal Cell Slightly Abnormal More Abnormal Malignant A AB ABC ABCD Gene changes
23 Passengers versus Drivers Normal Cell Slightly Abnormal More Abnormal Malignant Random passenger mutations X Y A XY Y AB Z ABC XY X ABCD Z α γα γα β Z Gene changes random passenger mutations are difficult to distinguish from driver mutations
24 How do we study the alterations/mutations? sequencing Small-scale changes - Deletion started with cytogenetics... - Inversion - Duplication Large-scale changes - Amplification - Chromosome translocation
25 Metaphase chromosomes
26
27 Karyotype
28 Philadelphia chromosome 9:22 22:9
29 Breast Cancer Karyotype, from primary culture Pandis et al (1998) Genes Chromosomes Cancer 22, 122
30 Amplification of N-MYC Chr 12 * One copy N-MYC Hundreds of copies
31 Breast Cancer Cell Line MDA-MB-361 Joanne Davidson
32 CGH Hybridization: Search for deletions and amplifications Amplification EGFreceptor (ERBB/ HER-1) Number of copies Genome position glioblastoma Deletion P16/CDKN2A/INK4A implicated in senescence
33 Examples of mutations Tyrosine kinases and signalling downstream from them
34 Receptor Tyrosine Kinase (RTK) signalling pathways RAS Grb2, SoS B-RAF MAP Kinase pathway EGF EGF-Receptor / ERBB, HER-1 PIP2/ PI3KCA PIP3 AKT ERBB2/HER-2 PTEN tyrosine kinases
35 POINT Mutations in RTK signalling pathways RAS Grb2, SoS B-RAF MAP Kinase pathway EGF EGF-Receptor A.k.a ERBB, HER-1 Ras GTP (ac,ve) PI3KCA PIP3 AKT SOS PTEN GAP ERBB2/HER-2 Ras GDP (inac,ve)
36 POINT Mutations in RTK signalling pathways EGF EGF-Receptor RAS Grb2, SoS B-RAF RAS family: HRAS, KRAS, NRAS MAP Kinase pathway PI3KCA PIP3 AKT ERBB2/HER-2 PTEN
37 POINT Mutations in RTK signalling pathways RAS Grb2, SoS B-RAF MAP Kinase pathway EGF EGF-Receptor PI3KCA ERBB2/HER-2 - Activating mutations, act like ras mutations. PIP3K AKT - In tumours that otherwise have Ras PTEN mutations e.g. 60% of melanomas, some colon cancers - Commonest mutation V600E (valine 600 -> glutamic acid),
38 BRAF V600E activation valine glutamic acid V T599 Activation segment is thought to move when Thr599 is phosphorylated, activating kinase. V600E where valine replaced by Gutamic acid doesn t need phosphorylation. Wan et al, 2004 PMID
39 POINT Mutations in RTK signalling pathways RAS Grb2, SoS B-RAF MAP Kinase pathway EGF EGF-Receptor PI3KCA ERBB2/HER-2 notes: PIP3 AKT activating mutations are highlyspecific PTEN pathways mutated rather than genes
40 POINT Mutations in RTK signalling pathways RAS Grb2, SoS B-RAF MAP Kinase pathway EGF EGF-Receptor PI3KCA ERBB2/HER-2 - Activating mutations. - One PIP3K of the Common AKT mutations - E542K (glutamic acid 542 -> lysine) PTEN - 40% of breast cancers, several other cancers
41 POINT Mutations in RTK signalling pathways RAS Grb2, SoS B-RAF MAP Kinase pathway EGF EGF-Receptor PI3KCA PIP3 AKT PTEN ERBB2/HER-2 Both occasionally point mutated in lung cancers
42 POINT Mutations in RTK signalling pathways RAS Grb2, SoS B-RAF MAP Kinase pathway EGF EGF-Receptor PI3KCA PIP3 AKT ERBB2/HER-2 PTEN
43 POINT Mutations in RTK signalling pathways RAS Grb2, SoS B-RAF MAP Kinase pathway EGF EGF-Receptor PI3KCA PIP3 PTEN AKT ERBB2/HER-2 RAS, RAF and PI3KCA feature in Vogelstein s model of colon cancer
44 Examples of alterations/mutations? - single base pair change - Indel = Small insert or deletion Small-scale changes - Deletion - Inversion - Duplication - Amplification - Chromosome translocation Large-scale changes
45 Mutations in RTK signalling pathways RAS Grb2, SoS B-RAF MAP Kinase pathway EGF EGF-Receptor PI3KCA PIP3 AKT PTEN ERBB2/HER-2 Deletions common (as well as point mutations)
46 What sorts of mutations alter the genes? - single base pair change - Indel = Small insert or deletion -> Small-scale changes - Deletion - Inversion - Duplication - Amplification - Chromosome translocation Large-scale changes
47 Mutations in RTK signalling pathways RAS Grb2, SoS B-RAF MAP Kinase pathway EGF EGF-Receptor Activated by tandem duplication! PI3KCA PIP3K AKT ERBB2/HER-2 PTEN
48 Tandem duplications causing gene fusion of BRAF About 2 Mb BRAF KIAA1549 tandem duplication BRAF KIAA-BRAF Astrocytomas KIAA1549 BRAF fusion
49 Mutations in RTK signalling pathways RAS Grb2, SoS B-RAF MAP Kinase pathway EGF EGF-Receptor PI3KCA take home message 3: PIP3 AKT same gene can be mutated in multiple PTEN ways ERBB2/HER-2
50 Mutations in RTK signalling pathways RAS Grb2, SoS B-RAF MAP Kinase pathway EGF EGF-Receptor both fused by translocation (rarely) PI3KCA PIP3 AKT ERBB2/HER-2 PTEN
51 Mutations in RTK signalling pathways RAS Grb2, SoS B-RAF MAP Kinase pathway EGF EGF-Receptor Amplified in brain tumours PI3KCA PIP3 AKT PTEN ERBB2/HER-2 Amplified in breast
52 What sorts of mutations alter the genes? - single base pair change - Indel = Small insert or deletion -> Small-scale changes - Deletion - Inversion - Duplication - Amplification - Chromosome translocation Large-scale changes
53 The first human cancer mutation: The Philadelphia chromosome translocation
54 Philadelphia chromosome 9:22 9:22 reciprocal translocation of chronic myeloid leukaemia fuses BCR to ABL 22:9
55 BCR-ABL fusion protein Abl is a tyrosine kinase, controlled by N-terminal domain N-term ABL kinase Normal Abl BCR BCR Normal Bcr likes to form dimers Tyrosine kinases are activated by dimerisation BCR BCR ABL kinase -> Activated tyrosine kinase ABL kinase Iconic translocation; diagnostic of CML; target for drug Glivec/Gleevec
56 There are fusion genes in common epithelial cancers
57 There are fusion genes in common epithelial cancers TMPRSS2-ERG ~50% prostate cancers Chr. 21 TMPRSS2 ERG Deletion TMPRSS2- ERG fusion
58 There are fusion genes in common epithelial cancers TMPRSS2-ERG ~50% prostate cancers promoter only (intact) transcription factor TMPRSS2- ERG fusion
59 Rearrangement more often INactivates a gene A rearrangement can inactivate a gene, - by breaking it or - by gene loss
60 Don t forget epigenetics! Examples of genes silenced by DNA methylation: Gene Function Cancer MLH1 mismatch DNA repair colorectal Cadherin E cell-cell adhesion lobular breast cell membrane adherens junction Cadherin Cadherin beta-catenin beta-catenin
61 Viruses e.g. several viruses encode proteins that block p53 and Rb: Human papillomavirus(es) (HPVs) proteins E6, E7 Adenovirus E1a, E1b
62 and hot topic LINE-1 retrotransposons? We know even less, but LINE1 retrotransposons form new insertions in some tumours can interrupt genes and turn genes on so far one inactivation of APC reported watch this space!
Cancer. The fundamental defect is. unregulated cell division. Properties of Cancerous Cells. Causes of Cancer. Altered growth and proliferation
Cancer The fundamental defect is unregulated cell division. Properties of Cancerous Cells Altered growth and proliferation Loss of growth factor dependence Loss of contact inhibition Immortalization Alterated
More informationCharacterisation of structural variation in breast. cancer genomes using paired-end sequencing on. the Illumina Genome Analyser
Characterisation of structural variation in breast cancer genomes using paired-end sequencing on the Illumina Genome Analyser Phil Stephens Cancer Genome Project Why is it important to study cancer? Why
More informationCancer. The fundamental defect is. unregulated cell division. Properties of Cancerous Cells. Causes of Cancer. Altered growth and proliferation
Cancer The fundamental defect is unregulated cell division. Properties of Cancerous Cells Altered growth and proliferation Loss of growth factor dependence Loss of contact inhibition Immortalization Alterated
More informationKaryotype analysis reveals transloction of chromosome 22 to 9 in CML chronic myelogenous leukemia has fusion protein Bcr-Abl
Chapt. 18 Cancer Molecular Biology of Cancer Student Learning Outcomes: Describe cancer diseases in which cells no longer respond Describe how cancers come from genomic mutations (inherited or somatic)
More informationOncogenes and Tumor. supressors
Oncogenes and Tumor supressors From history to therapeutics Serge ROCHE Neoplastic transformation TUMOR SURESSOR ONCOGENE ONCOGENES History 1911 1960 1980 2001 Transforming retrovirus RSV v-src is an oncogene
More informationIntroduction to Cancer Biology
Introduction to Cancer Biology Robin Hesketh Multiple choice questions (choose the one correct answer from the five choices) Which ONE of the following is a tumour suppressor? a. AKT b. APC c. BCL2 d.
More informationoncogenes-and- tumour-suppressor-genes)
Special topics in tumor biochemistry oncogenes-and- tumour-suppressor-genes) Speaker: Prof. Jiunn-Jye Chuu E-Mail: jjchuu@mail.stust.edu.tw Genetic Basis of Cancer Cancer-causing mutations Disease of aging
More informationMolecular Cell Biology. Prof. D. Karunagaran. Department of Biotechnology. Indian Institute of Technology Madras
Molecular Cell Biology Prof. D. Karunagaran Department of Biotechnology Indian Institute of Technology Madras Module 9 Molecular Basis of Cancer, Oncogenes and Tumor Suppressor Genes Lecture 2 Genes Associated
More informationDetermination Differentiation. determinated precursor specialized cell
Biology of Cancer -Developmental Biology: Determination and Differentiation -Cell Cycle Regulation -Tumor genes: Proto-Oncogenes, Tumor supressor genes -Tumor-Progression -Example for Tumor-Progression:
More informationOverview of the core ideas in cancer research
Overview of the core ideas in cancer research Paul Edwards Cancer Research UK Cambridge Institute and Department of Pathology, University of Cambridge This lecture Overview of the ideas that provide the
More informationOncogenes and Tumor Suppressors MCB 5068 November 12, 2013 Jason Weber
Oncogenes and Tumor Suppressors MCB 5068 November 12, 2013 Jason Weber jweber@dom.wustl.edu Oncogenes & Cancer DNA Tumor Viruses Simian Virus 40 p300 prb p53 Large T Antigen Human Adenovirus p300 E1A
More informationProf. R. V. Skibbens
Prof. R. V. Skibbens December 2, 2011 BIOS 10: BioScience in the 21 st Century Cell Cycle, Cell Division and Cancer (Part 2) Directionality The Cell Cycle clock goes in only one direction S-phase cells
More informationnumber Done by Corrected by Doctor Maha Shomaf
number 19 Done by Waseem Abo-Obeida Corrected by Abdullah Zreiqat Doctor Maha Shomaf Carcinogenesis: the molecular basis of cancer. Non-lethal genetic damage lies at the heart of carcinogenesis and leads
More informationDevelopment of Carcinoma Pathways
The Construction of Genetic Pathway to Colorectal Cancer Moriah Wright, MD Clinical Fellow in Colorectal Surgery Creighton University School of Medicine Management of Colon and Diseases February 23, 2019
More information609G: Concepts of Cancer Genetics and Treatments (3 credits)
Master of Chemical and Life Sciences Program College of Computer, Mathematical, and Natural Sciences 609G: Concepts of Cancer Genetics and Treatments (3 credits) Text books: Principles of Cancer Genetics,
More informationLecture 8 Neoplasia II. Dr. Nabila Hamdi MD, PhD
Lecture 8 Neoplasia II Dr. Nabila Hamdi MD, PhD ILOs Understand the definition of neoplasia. List the classification of neoplasia. Describe the general characters of benign tumors. Understand the nomenclature
More informationNeoplasia 18 lecture 6. Dr Heyam Awad MD, FRCPath
Neoplasia 18 lecture 6 Dr Heyam Awad MD, FRCPath ILOS 1. understand the role of TGF beta, contact inhibition and APC in tumorigenesis. 2. implement the above knowledge in understanding histopathology reports.
More informationVIII Curso Internacional del PIRRECV. Some molecular mechanisms of cancer
VIII Curso Internacional del PIRRECV Some molecular mechanisms of cancer Laboratorio de Comunicaciones Celulares, Centro FONDAP Estudios Moleculares de la Celula (CEMC), ICBM, Facultad de Medicina, Universidad
More informationEmerging" hallmarks of cancer, a. Reprogramming of energy metabolism b. Evasion of the immune system, Enabling characteristics, a.
HALLMARKS OF CANCER - Together dictate the malignant phenotype. 1. Self-sufficiency in growth signals 2. Insensitivity to growth inhibitory signals 3. Evasion of cell death 4. Limitless replicative potential
More informationDeregulation of signal transduction and cell cycle in Cancer
Deregulation of signal transduction and cell cycle in Cancer Tuangporn Suthiphongchai, Ph.D. Department of Biochemistry Faculty of Science, Mahidol University Email: tuangporn.sut@mahidol.ac.th Room Pr324
More informationDiagnostic test Suggested website label Description Hospitals available
Diagnostic test Suggested website label Description Hospitals available Abbott Molecular Inc, PATHVYSION HER-2 DNA Probe Kit (FISH) PathVysion kit A diagnostic tool used to determine whether a particular
More informationCancer. Questions about cancer. What is cancer? What causes unregulated cell growth? What regulates cell growth? What causes DNA damage?
Questions about cancer What is cancer? Cancer Gil McVean, Department of Statistics, Oxford What causes unregulated cell growth? What regulates cell growth? What causes DNA damage? What are the steps in
More informationMohammed El-Khateeb. Tumor Genetics. MGL-12 May 13 th Chapter 22 slide 1 台大農藝系遺傳學
Mohammed El-Khateeb Tumor Genetics MGL-12 May 13 th 2014 台大農藝系遺傳學 601 20000 Chapter 22 slide 1 Cancer Genetics Types of Genetic Alterations in Cancer Evidence that Mutations Cause Cancer Multistage Model
More informationMOLECULAR BASIS OF ONCOGENESIS
MOLECULAR BASIS OF ONCOGENESIS MUDr. Jiří Vachtenheim, CSc. 1 Cell processes which result also in cell cycle effects. Differentiation. Differentiated cells are usually in the G0 phase of the cell cycle.
More informationComputer Science, Biology, and Biomedical Informatics (CoSBBI) Outline. Molecular Biology of Cancer AND. Goals/Expectations. David Boone 7/1/2015
Goals/Expectations Computer Science, Biology, and Biomedical (CoSBBI) We want to excite you about the world of computer science, biology, and biomedical informatics. Experience what it is like to be a
More informationCANCER. Inherited Cancer Syndromes. Affects 25% of US population. Kills 19% of US population (2nd largest killer after heart disease)
CANCER Affects 25% of US population Kills 19% of US population (2nd largest killer after heart disease) NOT one disease but 200-300 different defects Etiologic Factors In Cancer: Relative contributions
More informationSection D. Genes whose Mutation can lead to Initiation
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this
More informationMolecular biology :- Cancer genetics lecture 11
Molecular biology :- Cancer genetics lecture 11 -We have talked about 2 group of genes that is involved in cellular transformation : proto-oncogenes and tumour suppressor genes, and it isn t enough to
More informationIntroduction. Cancer Biology. Tumor-suppressor genes. Proto-oncogenes. DNA stability genes. Mechanisms of carcinogenesis.
Cancer Biology Chapter 18 Eric J. Hall., Amato Giaccia, Radiobiology for the Radiologist Introduction Tissue homeostasis depends on the regulated cell division and self-elimination (programmed cell death)
More informationBiology of cancer development in the GI tract
1 Genesis and progression of GI cancer a genetic disease Colorectal cancer Fearon and Vogelstein proposed a genetic model to explain the stepwise formation of colorectal cancer (CRC) from normal colonic
More informationCOPYRIGHTED MATERIAL. An Introduction to Cancer Cell Biology and Genetics CHAPTER 1 IN BRIEF 1.1 INTRODUCTION
CHAPTER 1 An Introduction to Cancer Cell Biology and Genetics IN BRIEF It is impossible to describe targeted cancer treatments without mentioning what it is they target. And when I try to explain what
More informationSection D: The Molecular Biology of Cancer
CHAPTER 19 THE ORGANIZATION AND CONTROL OF EUKARYOTIC GENOMES Section D: The Molecular Biology of Cancer 1. Cancer results from genetic changes that affect the cell cycle 2. Oncogene proteins and faulty
More informationCancer genetics
Cancer genetics General information about tumorogenesis. Cancer induced by viruses. The role of somatic mutations in cancer production. Oncogenes and Tumor Suppressor Genes (TSG). Hereditary cancer. 1
More informationRAS Genes. The ras superfamily of genes encodes small GTP binding proteins that are responsible for the regulation of many cellular processes.
۱ RAS Genes The ras superfamily of genes encodes small GTP binding proteins that are responsible for the regulation of many cellular processes. Oncogenic ras genes in human cells include H ras, N ras,
More informationContents. Preface XV Acknowledgments XXI List of Abbreviations XXIII About the Companion Website XXIX
Contents Preface XV Acknowledgments XXI List of Abbreviations XXIII About the Companion Website XXIX 1 General Aspects of Signal Transduction and Cancer Therapy 1 1.1 General Principles of Signal Transduction
More informationNeoplasia 2018 lecture 4. Dr Heyam Awad MD, FRCPath
Neoplasia 2018 lecture 4 Dr Heyam Awad MD, FRCPath ILOS To understand the concept of the hallmarks of cancer and that they are phenotypic changes needed in all cancer cells. To list the tumor enablers
More informationProf. R. V. Skibbens. Cell Cycle, Cell Division and Cancer (Part 2)
Prof. R. V. Skibbens November 22, 2010 BIOS 10: BioScience in the 21 st Century Cell Cycle, Cell Division and Cancer (Part 2) Directionality - clocks go in only one direction G1 doesn t have replication-inducing
More informationWhat causes cancer? Physical factors (radiation, ionization) Chemical factors (carcinogens) Biological factors (virus, bacteria, parasite)
Oncogenes What causes cancer? Chemical factors (carcinogens) Physical factors (radiation, ionization) Biological factors (virus, bacteria, parasite) DNA Mutation or damage Oncogenes Tumor suppressor genes
More informationPresent State of Gene Diagnosis and Future Prospects
Clinical Medicine: Cancer Present State of Gene Diagnosis and Future Prospects JMAJ 45(3): 118 124, 2002 Eiichi TAHARA Chairman, Hiroshima Cancer Seminar Foundation Abstract: The entire base sequence of
More informationBCHM3972 Human Molecular Cell Biology (Advanced) 2013 Course University of Sydney
BCHM3972 Human Molecular Cell Biology (Advanced) 2013 Course University of Sydney Page 2: Immune Mechanisms & Molecular Biology of Host Defence (Prof Campbell) Page 45: Infection and Implications for Cell
More informationGenetics of Cancer Lecture 32 Cancer II. Prof. Bevin Engelward, MIT Biological Engineering Department
Genetics of Cancer Lecture 32 Cancer II rof. Bevin Engelward, MIT Biological Engineering Department Why Cancer Matters New Cancer Cases in 1997 Cancer Deaths in 1997 Genetics of Cancer: Today: What types
More informationTUMOR-SUPPRESSOR GENES. Molecular Oncology Michael Lea
TUMOR-SUPPRESSOR GENES Molecular Oncology 2011 Michael Lea TUMOR-SUPPRESSOR GENES - Lecture Outline 1. Summary of tumor suppressor genes 2. P53 3. Rb 4. BRCA1 and 2 5. APC and DCC 6. PTEN and PPA2 7. LKB1
More informationGenomic Instability. Kent Nastiuk, PhD Dept. Cancer Genetics Roswell Park Cancer Institute. RPN-530 Oncology for Scientist-I October 18, 2016
Genomic Instability Kent Nastiuk, PhD Dept. Cancer Genetics Roswell Park Cancer Institute RPN-530 Oncology for Scientist-I October 18, 2016 Previous lecturers supplying slides/notes/inspiration Daniel
More informationOut-Patient Billing CPT Codes
Out-Patient Billing CPT Codes Updated Date: August 3, 08 Client Billed Molecular Tests HPV DNA Tissue Testing 8764 No Medicare Billed - Molecular Tests NeoARRAY NeoARRAY SNP/Cytogenetic No 89 NeoLAB NeoLAB
More informationMultistep nature of cancer development. Cancer genes
Multistep nature of cancer development Phenotypic progression loss of control over cell growth/death (neoplasm) invasiveness (carcinoma) distal spread (metastatic tumor) Genetic progression multiple genetic
More informationColon Cancer and Hereditary Cancer Syndromes
Colon Cancer and Hereditary Cancer Syndromes Gisela Keller Institute of Pathology Technische Universität München gisela.keller@lrz.tum.de Colon Cancer and Hereditary Cancer Syndromes epidemiology models
More informationCELL CYCLE REGULATION AND CANCER. Cellular Reproduction II
CELL CYCLE REGULATION AND CANCER Cellular Reproduction II THE CELL CYCLE Interphase G1- gap phase 1- cell grows and develops S- DNA synthesis phase- cell replicates each chromosome G2- gap phase 2- cell
More informationGenomic instability. Amin Mahpour
Genomic instability Amin Mahpour 1 Some questions to ponder What is Genomic instability? What factors contribute to the genomic integrity? How we identify these aberrations? 2 PART I: MOLECULAR BIOLOGY
More informationTHE HALLMARKS OF CANCER
THE HALLMARKS OF CANCER ONCOGENES - Most of the oncogenes were first identified in retroviruses: EGFR (ErbB), Src, Ras, Myc, PI3K and others (slightly more than 30) - Mutated cellular genes incorporated
More informationGenomic analysis of childhood High grade glial (HGG) brain tumors
Genomic analysis of childhood High grade glial (HGG) brain tumors Linda D Cooley Children s Mercy, Kansas City The Children s Mercy Hospital, 2017 Genomic analysis of childhood High grade glial (HGG) brain
More informationChapter 18- Oncogenes, tumor suppressors & Cancer
Chapter 18- Oncogenes, tumor suppressors & Cancer - Previously we have talked about cancer which is an uncontrolled cell proliferation and we have discussed about the definition of benign, malignant, metastasis
More informationCell cycle, signaling to cell cycle, and molecular basis of oncogenesis
Cell cycle, signaling to cell cycle, and molecular basis of oncogenesis MUDr. Jiří Vachtenheim, CSc. CELL CYCLE - SUMMARY Basic terminology: Cyclins conserved proteins with homologous regions; their cellular
More informationPrinciples of Genetics and Molecular Biology
Cell signaling Dr. Diala Abu-Hassan, DDS, PhD School of Medicine Dr.abuhassand@gmail.com Principles of Genetics and Molecular Biology www.cs.montana.edu Modes of cell signaling Direct interaction of a
More informationActivation of cellular proto-oncogenes to oncogenes. How was active Ras identified?
Dominant Acting Oncogenes Eugene E. Marcantonio, M.D. Ph.D. Oncogenes are altered forms of normal cellular genes called proto-oncogenes that are involved in pathways regulating cell growth, differentiation,
More informationOsamu Tetsu, MD, PhD Associate Professor Department of Otolaryngology-Head and Neck Surgery School of Medicine, University of California, San
Osamu Tetsu, MD, PhD Associate Professor Department of Otolaryngology-Head and Neck Surgery School of Medicine, University of California, San Francisco Lung Cancer Classification Pathological Classification
More informationTumor suppressor genes D R. S H O S S E I N I - A S L
Tumor suppressor genes 1 D R. S H O S S E I N I - A S L What is a Tumor Suppressor Gene? 2 A tumor suppressor gene is a type of cancer gene that is created by loss-of function mutations. In contrast to
More informationNext Generation Sequencing in Clinical Practice: Impact on Therapeutic Decision Making
Next Generation Sequencing in Clinical Practice: Impact on Therapeutic Decision Making November 20, 2014 Capturing Value in Next Generation Sequencing Symposium Douglas Johnson MD, MSCI Vanderbilt-Ingram
More informationMohammed El-Khateeb. Tumor Genetics. MGL-12 July 21 st 2013 台大農藝系遺傳學 Chapter 22 slide 1
Mohammed El-Khateeb Tumor Genetics MGL-12 July 21 st 2013 台大農藝系遺傳學 601 20000 Chapter 22 slide 1 Cellular Basis of Cancer Cancer is a collection of diseases characterized by abnormal and uncontrolled growth
More informationCancer Genetics. What is Cancer? Cancer Classification. Medical Genetics. Uncontrolled growth of cells. Not all tumors are cancerous
Session8 Medical Genetics Cancer Genetics J avad Jamshidi F a s a U n i v e r s i t y o f M e d i c a l S c i e n c e s, N o v e m b e r 2 0 1 7 What is Cancer? Uncontrolled growth of cells Not all tumors
More informationChapt 15: Molecular Genetics of Cell Cycle and Cancer
Chapt 15: Molecular Genetics of Cell Cycle and Cancer Student Learning Outcomes: Describe the cell cycle: steps taken by a cell to duplicate itself = cell division; Interphase (G1, S and G2), Mitosis.
More informationCell Cycle and Cancer
142 8. Cell Cycle and Cancer NOTES CELL CYCLE G 0 state o Resting cells may re-enter the cell cycle Nondividing cells (skeletal and cardiac muscle, neurons) o Have left the cell cycle and cannot undergo
More informationMolecular biology of colorectal cancer
Molecular biology of colorectal cancer Phil Quirke Yorkshire Cancer Research Centenary Professor of Pathology University of Leeds, UK Rapid pace of molecular change Sequencing changes 2012 1,000 genomes
More informationMolecular Oncology, oncology parameters see each test
Molecular Oncology, oncology parameters see each test DPD deficiency Dihydropyrimidine dehydrogenase deficiency (DPD deficiency) is an autosomal recessive metabolic disorder in which there is absent or
More informationA class of genes that normally suppress cell proliferation. p53 and Rb..ect. suppressor gene products can release cells. hyperproliferation.
Tumor Suppressor Genes A class of genes that normally suppress cell proliferation. p53 and Rb..ect Mutations that inactivate the tumor suppressor gene products can release cells from growth suppression
More informationVariations in Chromosome Structure & Function. Ch. 8
Variations in Chromosome Structure & Function Ch. 8 1 INTRODUCTION! Genetic variation refers to differences between members of the same species or those of different species Allelic variations are due
More informationGenomic Medicine: What every pathologist needs to know
Genomic Medicine: What every pathologist needs to know Stephen P. Ethier, Ph.D. Professor, Department of Pathology and Laboratory Medicine, MUSC Director, MUSC Center for Genomic Medicine Genomics and
More informationRole of FISH in Hematological Cancers
Role of FISH in Hematological Cancers Thomas S.K. Wan PhD,FRCPath,FFSc(RCPA) Honorary Professor, Department of Pathology & Clinical Biochemistry, Queen Mary Hospital, University of Hong Kong. e-mail: wantsk@hku.hk
More informationCELL CYCLE MOLECULAR BASIS OF ONCOGENESIS
CELL CYCLE MOLECULAR BASIS OF ONCOGENESIS Summary of the regulation of cyclin/cdk complexes during celll cycle Cell cycle phase Cyclin-cdk complex inhibitor activation Substrate(s) G1 Cyclin D/cdk 4,6
More informationp53 and Apoptosis: Master Guardian and Executioner Part 2
p53 and Apoptosis: Master Guardian and Executioner Part 2 p14arf in human cells is a antagonist of Mdm2. The expression of ARF causes a rapid increase in p53 levels, so what would you suggest?.. The enemy
More informationBasic tumor nomenclature
Jonas Nilsson jonas.a.nilsson@surgery.gu.se Sahlgrenska Cancer Center Bilder gjorda av Per Holmfeldt och Jonas Nilsson Benign tumor Basic tumor nomenclature Malignant tumor = cancer Metastasis Carcinoma:
More informationGenetics and Cancer Ch 20
Genetics and Cancer Ch 20 Cancer is genetic Hereditary cancers Predisposition genes Ex. some forms of colon cancer Sporadic cancers ~90% of cancers Descendants of cancerous cells all cancerous (clonal)
More informationKRAS: ONE ACTOR, MANY POTENTIAL ROLES IN DIAGNOSIS
UNIVERSITÀ DEGLI STUDI DI PALERMO Scuola di Specializzazione in Biochimica Clinica Direttore Prof. Marcello Ciaccio KRAS: ONE ACTOR, MANY POTENTIAL ROLES IN DIAGNOSIS Loredana Bruno KRAS gene Proto-oncogene
More informationBIO360 Fall 2013 Quiz 1
BIO360 Fall 2013 Quiz 1 1. Examine the diagram below. There are two homologous copies of chromosome one and the allele of YFG carried on the light gray chromosome has undergone a loss-of-function mutation.
More informationTransformation of Normal HMECs (Human Mammary Epithelial Cells) into Metastatic Breast Cancer Cells: Introduction - The Broad Picture:
Transformation of Normal HMECs (Human Mammary Epithelial Cells) into Metastatic Breast Cancer Cells: Introduction - The Broad Picture: Spandana Baruah December, 2016 Cancer is defined as: «A disease caused
More informationMolecular Markers in Acute Leukemia. Dr Muhd Zanapiah Zakaria Hospital Ampang
Molecular Markers in Acute Leukemia Dr Muhd Zanapiah Zakaria Hospital Ampang Molecular Markers Useful at diagnosis Classify groups and prognosis Development of more specific therapies Application of risk-adjusted
More informationPlasma-Seq conducted with blood from male individuals without cancer.
Supplementary Figures Supplementary Figure 1 Plasma-Seq conducted with blood from male individuals without cancer. Copy number patterns established from plasma samples of male individuals without cancer
More informationChapter 4 Cellular Oncogenes ~ 4.6 -
Chapter 4 Cellular Oncogenes - 4.2 ~ 4.6 - Many retroviruses carrying oncogenes have been found in chickens and mice However, attempts undertaken during the 1970s to isolate viruses from most types of
More informationChapter 16 Mutations. Practice Questions:
Biology 234 J. G. Doheny Chapter 16 Mutations Practice Questions: Answer the following questions with one or two sentences. 1. List the name of one test that can be used to identify mutagens. 2. What is
More informationCurrent and future applications of Molecular Pathology. Kathy Walsh Clinical Scientist NHS Lothian
Current and future applications of Molecular Pathology Kathy Walsh Clinical Scientist NHS Lothian Molecular Pathology in Solid tumours Cancer type Genes tested Purpose Associated treatments Non small cell
More informationBIO360 Quiz #1. September 14, Name five of the six Hallmarks of Cancer (not emerging hallmarks or enabling characteristics ): (5 points)
Name: BIO360 Quiz #1 September 14, 2012 1. Name five of the six Hallmarks of Cancer (not emerging hallmarks or enabling characteristics ): (5 points) 2. The controversial hypothesis that only a small subset
More informationIntroduction to Genetics
Introduction to Genetics Table of contents Chromosome DNA Protein synthesis Mutation Genetic disorder Relationship between genes and cancer Genetic testing Technical concern 2 All living organisms consist
More informationIntroduction to Cancer Bioinformatics and cancer biology. Anthony Gitter Cancer Bioinformatics (BMI 826/CS 838) January 20, 2015
Introduction to Cancer Bioinformatics and cancer biology Anthony Gitter Cancer Bioinformatics (BMI 826/CS 838) January 20, 2015 Why cancer bioinformatics? Devastating disease, no cure on the horizon Major
More informationC) The graph should look exactly like the graph on the left (Mut1 cells + Mating Pheromone for 3 hours at 25 degrees). The cells arrest in G1.
706-2000-Exam 4 Answer Key 1) The question asks you to explain peaks A and B in the top graph. The other two graphs were there to give you hints. The question did not ask for these other two graphs to
More informationGenetics and Genomics in Medicine Chapter 10. Questions & Answers
Genetics and Genomics in Medicine Chapter 10 Multiple Choice Questions Questions & Answers Question 10.1 Which, if any, of the following statements is false? a) The p53 tumor suppressor regulates the G
More informationTargeted therapy & Tumor molecular profile. Anton Tikhonov V Bioinformatics Summer School, 2017
Targeted therapy & Tumor molecular profile Anton Tikhonov V Bioinformatics Summer School, 2017 What exactly is targeted therapy? It has target It was rationally designed Its target was discovered before
More informationTest Name Results Units Bio. Ref. Interval. Positive
LL - LL-ROHINI (NATIONAL REFERENCE 135091534 Age 36 Years Gender Female 1/9/2017 120000AM 1/9/2017 105316AM 2/9/2017 104147AM Ref By Final LEUKEMIA GENETIC ROFILE ANY SIX MARKERS, CR QUALITATIVE AML ETO
More informationDr C K Kwan. Associate Consultant, Queen Elizabeth Hospital, HKSAR Honorary member, Targeted Therapy Team, ICR, UK
HA Convention 2013 Dr C K Kwan MBChB, FRCR, FHKCR, FHKAM, MPM, CPI, MAppMgt(Hlth) Associate Consultant, Queen Elizabeth Hospital, HKSAR Honorary member, Targeted Therapy Team, ICR, UK To personalize cancer
More informationOrigin of oncogenes? Oncogenes and Proto-oncogenes. Jekyll and Hyde. Oncogene hypothesis. Retroviral oncogenes and cell proto-oncogenes
Oncogenes and Proto-oncogenes Jekyll and Hyde A double edged sword Origin of oncogenes? Oncogene hypothesis Retroviral oncogenes and cell proto-oncogenes (v-onc) (c-onc) The role of c-onc in cancer How
More informationSignaling. Dr. Sujata Persad Katz Group Centre for Pharmacy & Health research
Signaling Dr. Sujata Persad 3-020 Katz Group Centre for Pharmacy & Health research E-mail:sujata.persad@ualberta.ca 1 Growth Factor Receptors and Other Signaling Pathways What we will cover today: How
More informationOncogenes and tumour suppressor genes
Cancer mutations disrupt cellular homeostasis Oncogenes and tumour suppressor genes Oncogenes: Gain of function mutations Proto-oncogene Tumour suppressor genes: loss of function mutations Normal cell
More informationSureSelect Cancer All-In-One Custom and Catalog NGS Assays
SureSelect Cancer All-In-One Custom and Catalog NGS Assays Detect all cancer-relevant variants in a single SureSelect assay SNV Indel TL SNV Indel TL Single DNA input Single AIO assay Single data analysis
More informationThe Pathology of Neoplasia Part II
The Pathology of Neoplasia Part II February 2018 PAUL BOGNER, MD A S S O C I A T E P R O F E S S O R O F O N C O L O G Y P A T H O L O G Y A N D D E R M A T O L O G Y Clinical goals of cancer pathology
More informationHST.161 Molecular Biology and Genetics in Modern Medicine Fall 2007
MIT OpenCourseWare http://ocw.mit.edu HST.161 Molecular Biology and Genetics in Modern Medicine Fall 2007 For information about citing these materials or our Terms of Use, visit: http://ocw.mit.edu/terms.
More informationMultistep Carcinogenesis
Multistep Carcinogenesis M.Rosemann, Institute for Radiation Biology Helmholtz Center Munich, Research Centre for Health and Environment The Hallmarks of Cancer D.Hanahan, Cell 2011 The Hallmarks of Cancer
More informationEGFR: fundamenteel en klinisch
EGFR: fundamenteel en klinisch Guido Lammering MAASTRO Clinic Maastricht, NL What is EGFR?? The EGFR some facts 1186 amino acids 170 kda Expressed by all cells of epithelial origin Increased activation
More informationColon cancer: practical molecular diagnostics. Wade S. Samowitz, M.D. University of Utah and ARUP
Colon cancer: practical molecular diagnostics Wade S. Samowitz, M.D. University of Utah and ARUP Disclosure Dr. Samowitz may receive royalties in the future related to the Ventana BRAF V600E antibody.
More informationMSI positive MSI negative
Pritchard et al. 2014 Supplementary Figure 1 MSI positive MSI negative Hypermutated Median: 673 Average: 659.2 Non-Hypermutated Median: 37.5 Average: 43.6 Supplementary Figure 1: Somatic Mutation Burden
More informationA. Incorrect! All the cells have the same set of genes. (D)Because different types of cells have different types of transcriptional factors.
Genetics - Problem Drill 21: Cytogenetics and Chromosomal Mutation No. 1 of 10 1. Why do some cells express one set of genes while other cells express a different set of genes during development? (A) Because
More informationSTRUCTURAL CHROMOSOMAL ABERRATIONS
STRUCTURAL CHROMOSOMAL ABERRATIONS Structural chromosomal aberrations cause structural abnormalities in chromosome structure. They alter the sequence or the kind of genes present in chromosome. These are
More informationGlioblastoma pathophysiology: or a
Glioblastoma pathophysiology: A or a? M.J. van den Bent The Brain Tumor Center at Erasmus MC Cancer Center Rotterdam, the Netherlands Pathophysiology: pathophysiology seeks to explain the physiological
More information